P-glycoprotein Inhibition for Optimal Drug Delivery

P-glycoprotein Inhibition for Optimal Drug Delivery

Show other versions (1)

P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the body and is responsible for limiting cellular uptake and the distribution of xenobiotics and toxic substances. Hundreds of structurally diverse therapeutic agents are substrates to it and it impedes the absor...

Full description

Bibliographic Details
Main Author:	Md. Lutful Amin
Format:	Article
Language:	English
Published:	AboutScience Srl 2013-01-01
Series:	Drug Target Insights
Online Access:	https://doi.org/10.4137/DTI.S12519

Similar Items

P-glycoprotein Inhibition for Optimal Drug Delivery
by: Md. Lutful Amin
Published: (2013-08-01)

The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation.
by: S M D K Ganga Senarathna, et al.
Published: (2016-01-01)

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
by: Yusuke Kono, et al.
Published: (2021-03-01)

3,3′,4,4′,5-Pentachlorobiphenyl Inhibits Drug Efflux Through P-Glycoprotein in KB-3 Cells Expressing Mutant Human P-Glycoprotein
by: Hiroshi Fujise, et al.
Published: (2004-01-01)

Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
by: Jiun-I Lai, et al.
Published: (2020-11-01)

Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer
by: Jing Mao, et al.
Published: (2021-02-01)

Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein.
by: Hiroki Morishita, et al.
Published: (2020-01-01)

Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016-01-01)

Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
by: Saikat Dewanjee, et al.
Published: (2017-05-01)

P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
by: Andrea Picchianti-Diamanti, et al.
Published: (2014-03-01)

Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-Glycoprotein
by: Yu-Ning Teng, et al.
Published: (2020-01-01)

Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein.
by: Zsolt Bikadi, et al.
Published: (2011-01-01)

Reversal Effect of Oxypeucedanin on P-glycoprotein-mediated Drug Transport
by: Wei Dong, et al.
Published: (2018-07-01)

Computational models for predicting drug transport mediated by P-glycoprotein
by: Erić Slavica, et al.
Published: (2015-01-01)

Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms
by: Paras Famta, et al.
Published: (2021-01-01)

Chitosan-based siRNA delivery to rat brain endothelial and glioma cells for optimization of P-glycoprotein knockdown in vitro
by: Wold, Christian Winther
Published: (2012)

The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
by: Gao W, et al.
Published: (2014-07-01)

The ability of gallate and pyrogallol moieties of catechins to inhibit P-glycoprotein function
by: Narumi Sugihara, et al.
Published: (2011-10-01)

Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
by: Tomohiro Nabekura, et al.
Published: (2020-03-01)

Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies
by: Laura Evgin, et al.
Published: (2016-01-01)

Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach.
by: Jostein Malmo, et al.
Published: (2013-01-01)

Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs
by: Marika Ruponen, et al.
Published: (2021-01-01)

P-glycoprotein and chiral antidepressant drugs : Pharmacokinetic, pharmacogenetic and toxicological aspects
by: Karlsson, Louise
Published: (2012)

Impact of Extracellular Acidity on the Activity of P-glycoprotein and the Cytotoxicity of Chemotherapeutic Drugs
by: Oliver Thews, et al.
Published: (2006-02-01)

The effects of bovine serum albumin (BSA) on the drug transport by P-glycoprotein
by: Hsu, Chu-Yin, et al.
Published: (1998)

Inhibition of P-glycoprotein–Mediated Efflux of Digoxin and Its Metabolites by Macrolide Antibiotics
by: Jeff Hughes, et al.
Published: (2010-01-01)

Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
by: Hongping Min, et al.
Published: (2017-01-01)

Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux
by: Guixiang Pan, et al.
Published: (2016-02-01)

Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane
by: Vinaya Phatak, et al.
Published: (2021-02-01)

Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer
by: Safiulla Basha Syed, et al.
Published: (2017-08-01)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
by: Hande Beklen, et al.
Published: (2020-08-01)

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
by: Sungpil Yoon, et al.
Published: (2021-03-01)

Organisation of the nucleotide-binding domains of the multi-drug resistance transporter, P-glycoprotein
by: Blott, Emma-Jane
Published: (1999)

Dynamics, Conformational Transition and Drug Interactions of P-glycoprotein upon ATP Binding
by: Hui-Hsuan Tu, et al.
Published: (2005)

The generation of recombinant phage antibodies to the multiple drug resistance protein P-glycoprotein
by: McLaren, Susan R. A.
Published: (1997)

Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs
by: Linardi Renata Lehn, et al.
Published: (2006-01-01)

Modulation of Intestinal P-glycoprotein in SD Rats by Traditional Chinese Medicines and Drug-Drug Interaction with Fexofenadine
by: Kao, Ting-Kai, et al.
Published: (2016)

CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy
by: Emily Foran, et al.
Published: (2016-04-01)

Prediction of promiscuous p-glycoprotein inhibition using a novel machine learning scheme.
by: Max K Leong, et al.
Published: (2012-01-01)

Optimization of Drug Delivery by Drug-Eluting Stents.
by: Franz Bozsak, et al.
Published: (2015-01-01)